Vertex Pharmaceuticals (NASDAQ:VRTX), a leading biotechnology company known for its cystic fibrosis (CF) treatments, is at a critical juncture as it seeks to diversify its portfolio and maintain its ...
In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $470.37, marking a +1.88% move from the previous day.
Some people are fair-weather friends; others are lifelong. It's a similar story with stocks. Some you might hold only ...
H.C. Wainwright analyst Andrew Fein increased the price target for Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) to $550 from the previous $535, while maintaining a Buy rating on the stock.
AbbVie, Vertex Pharmaceuticals, and Thermo Fisher Scientific are the three Biotech stocks to watch today, according to ...
Precision medicine is revolutionizing healthcare, and these genomic stocks are leading the way. Therefore, as this sector ...
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price ...
U.S. stock markets have been experiencing heightened volatility due to recent tariff announcements and ongoing concerns about trade policies, which have impacted major indices like the S&P 500 and ...
On Jan. 30, the U.S. Food and Drug Administration (FDA) approved a new drug called suzetrigine to treat moderate-to-severe ...
The largest school district in El Paso County is making some pretty big changes to its school calendar for the remainder of ...
A South Sacramento California Highway Patrol reported an Amazon truck crashed on Highway 50 at Howe Avenue, pushing through ...
Cost of Tariffs: How increases on imported goods will impact Ohio, Kentucky and Indiana residents Ye shocked at the Grammys ...